Sandra is a biochemist with a background in molecular and cellular biology, protein biochemistry, and phage display. She recently earned her MS in Chemistry from Boston College and graduated from Worcester State University with a BS in Chemistry. She generated several phage libraries suited for covalent warhead modification throughout her doctoral studies and concentrated on perfecting the phage display screening platform against cells in-vitro in order to probe the cell-surface proteome of cancer cells.
This person is not in any offices
BigHat Bio
1 followers
BigHat’s mission is to improve human health by making it far easier to design advanced, next-generation antibody therapeutics. Our AI-enabled experimental platform integrates a high-speed characterization or “wet” lab with machine learning technologies to speed the antibody engineering process. When applied, these design capabilities have the potential to drive the development of new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases.